| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/22/2001 | CN1309552A Pharmaceutical, hygienic and/or cosmetic compositions contg. sea water and uses |
| 08/22/2001 | CN1309549A Spine distraction implant |
| 08/22/2001 | CN1309133A Neotoralactone, its derivatives and their application in reducing fat and lossing weight |
| 08/22/2001 | CN1309132A Magnesium zinc fructose diphosphate and its preparing process and application in preparing medicines |
| 08/22/2001 | CN1309127A Piperazidine deriv. and preparing method thereof |
| 08/22/2001 | CN1309125A Composition of gambogic acid compounds with anticancer activity and its preparing process |
| 08/22/2001 | CN1308939A Ketonic acid preparation for treating nephrosis |
| 08/22/2001 | CN1308938A Antalgic and sedative oral etomidate preparation |
| 08/22/2001 | CN1308937A Method for preparing microcapsule |
| 08/22/2001 | CN1069901C N-benzyldioxothiazolidylbenzamide derivs. and process for producing same |
| 08/22/2001 | CN1069895C Legionella specific antibiotic, microorganism producing antibiotic and process for producing same |
| 08/22/2001 | CN1069837C Drope for treating cold |
| 08/22/2001 | CN1069831C Patch for treating spur |
| 08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
| 08/22/2001 | CN1069828C Contraceptive |
| 08/22/2001 | CN1069826C Freezing-dried tetracaine hydrochloride powder injection |
| 08/21/2001 | US6278040 Receptor-deficient mice and cell lines derived therefrom, and uses thereof |
| 08/21/2001 | US6278013 Optionally substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids and their derivatives |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277999 As chemical intermediate for preparation of drugs |
| 08/21/2001 | US6277993 Useful as a benzodiazepine inverse agonist, for example, as psychoanaleptic drug or drug for treatment of dysmnesia in senile dementia or alzheimer's disease |
| 08/21/2001 | US6277992 Useful as an intermediate for preparing camptothecin derivatives having antitumor activities |
| 08/21/2001 | US6277991 For treatment of migraine, non-insulin dependent diabetes mellitus, sepsis, inflammation, incontinence, vasomotor disturbances such as hot flushes or hot flashes |
| 08/21/2001 | US6277989 Quinazoline derivatives as medicaments |
| 08/21/2001 | US6277987 Sulfonylamino acid and sulfonylamino hydroxamic acid derivatives |
| 08/21/2001 | US6277985 As antibiotics; water solubility; in prodrugs |
| 08/21/2001 | US6277980 Mixed backbone oligonucleotide analog having nucleotide sequence complementary to e6/e7 genes; has phosphorothioate bonds and at least one other phosphorus linking group or modification; viricides |
| 08/21/2001 | US6277977 cDNA clone HAPOI67 that encodes a human 7-transmembrane receptor |
| 08/21/2001 | US6277972 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells |
| 08/21/2001 | US6277965 Amino acid sequence of cysteinyl trna (transfer ribonucleic acid) synthetase from chlamydia; bactericides; bacteriostats; enzyme inhibitors; drug screening; diagnosis; vaccines |
| 08/21/2001 | US6277891 Nitric oxide inhibits rhinovirus infection |
| 08/21/2001 | US6277890 Treatment of pulmonary disorders with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli) |
| 08/21/2001 | US6277888 Drug composition |
| 08/21/2001 | US6277887 Methods for treating Parkinson's disease using optically pure (−)-bupropion |
| 08/21/2001 | US6277886 Pharmaceutical compositions comprising S-(−)-N-propargyl-1-aminoindan |
| 08/21/2001 | US6277885 Inhibitors of tumor necrosis factor-alpha converting enzyme |
| 08/21/2001 | US6277884 Treatment of sexual dysfunction with N-hydroxyguanidine compounds |
| 08/21/2001 | US6277883 Administering organosulfur compound |
| 08/21/2001 | US6277882 Skin disorders |
| 08/21/2001 | US6277881 Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids |
| 08/21/2001 | US6277880 Chemical compounds |
| 08/21/2001 | US6277878 Substituted indole compounds as anti-inflammatory and analgesic agents |
| 08/21/2001 | US6277876 Antiinflammatory agents; prevent tissue degradation |
| 08/21/2001 | US6277875 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia |
| 08/21/2001 | US6277874 Methods for the treatment of apolipoprotein E related diseases |
| 08/21/2001 | US6277872 Antiischemic agents; brain disorders |
| 08/21/2001 | US6277870 Use |
| 08/21/2001 | US6277869 Pharmaceutical composition |
| 08/21/2001 | US6277868 Bactericides; skin disorders |
| 08/21/2001 | US6277866 Alzheimer's disease |
| 08/21/2001 | US6277865 Anticoagulants |
| 08/21/2001 | US6277864 Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
| 08/21/2001 | US6277862 Quinoline derivatives |
| 08/21/2001 | US6277861 For treatment and prophylaxis of nervous system disorders, psychological disorders, muscular disorders, drug addiction withdrawal, pain |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/21/2001 | US6277855 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 08/21/2001 | US6277853 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 08/21/2001 | US6277852 Piperazinyl 5-HT1 agonists and antagonists |
| 08/21/2001 | US6277851 Bicyclic amino-pyrazinone compounds |
| 08/21/2001 | US6277846 Use of platelet activating factor antagonists as anti-pruritic agents |
| 08/21/2001 | US6277845 Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates |
| 08/21/2001 | US6277844 Administering a benzodiazepine derivative for treatment of breast, prostate and glial cell cancer |
| 08/21/2001 | US6277842 Dietary supplemental method for fat and weight reduction |
| 08/21/2001 | US6277841 Quinoline ligands and metal complexes for diagnosis and therapy |
| 08/21/2001 | US6277840 Antiinflammatory agents |
| 08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
| 08/21/2001 | US6277838 Methods for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| 08/21/2001 | US6277837 Treatment of psoriasis, leukemia, cancers, osteoporosis |
| 08/21/2001 | US6277836 Methods and compositions for treating inflammatory bowel disease |
| 08/21/2001 | US6277835 Method of tumor treatment |
| 08/21/2001 | US6277834 Agents for relieving side effects of adrenal cortex hormone |
| 08/21/2001 | US6277833 3-hydroxy-3-methyl-glutaryl coenzyme a (hgm--coa) reductase inhibitors which retard cholesterol biosynthesis |
| 08/21/2001 | US6277831 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 08/21/2001 | US6277829 Dissolving azithromycin in solution of polybasic phosphate and citric acid; treatment of conjunctivitis, keratitis and blepharitis |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | US6277813 Colostrum derived growth factor |
| 08/21/2001 | US6277635 Use of interleukin-10 to produce a population of suppressor cells |
| 08/21/2001 | US6277634 Hybridized with target rna to be cleaved; medical diagnosis or gene therapy, drugs |
| 08/21/2001 | US6277613 TRF1 binding protein, methods of use thereof |
| 08/21/2001 | US6277599 Monoclonal antiboby for the preferential killing of tumors; for diagnosis of cancer; for the treatment of cancer |
| 08/21/2001 | US6277585 Vertebrate unc-5 proteins which function as receptor proteins for netrins, a family of cell guidance proteins; use in diagnosis, therapy and in the biopharmaceutical industry |
| 08/21/2001 | US6277574 Genes associated with diseases of the kidney |
| 08/21/2001 | US6277417 (a) protein, (b) carbohydrates, (c) fatty acids, and (d) from about 0.1% to about 4.0% by weight of the carotenoid astaxanthin; prevent and treat benign prostate hyperplasia (bph) and prostate cancer in human males. |
| 08/21/2001 | US6277415 Pediculocidal and veterinary compositions |
| 08/21/2001 | US6277413 Biodegradable compositions for the controlled release of encapsulated substances |
| 08/21/2001 | US6277412 A core and an enteric coating, the core including, as a pharmaceutical active compound, 5-aminosalicylic acid homogeneously dispersed in a non gel-forming polymer matrix which extends through the entire core |
| 08/21/2001 | US6277411 Pharmaceutical formulation containing DFMO for the treatment of cancer |
| 08/21/2001 | US6277405 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/21/2001 | US6277402 Administering to a patient transdermally a histamine h2 agonist, in an amount effective to stimulate and sustain production of cyclic amp and a phosphodiesterase inhibitor |
| 08/21/2001 | US6277401 Drug delivery device |
| 08/21/2001 | US6277400 Extendible transdermal therapeutic system |
| 08/21/2001 | US6277398 Analgesic drug composition containing a capsaicinoid and potentiator therefor |
| 08/21/2001 | US6277393 Systemic and/or local (topical) application of tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases, traumas and damages of nervous system |
| 08/21/2001 | US6277387 Use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF αantagonist in a cosmetic, pharmaceutical or dermatological composition and composition obtained |
| 08/21/2001 | US6277384 The amount of opioid antagonist included in the combination product provides at least a mildly negative, ?aversive? experience in physically dependent addicts (e.g., precipitated abstinence syndrome). |
| 08/21/2001 | US6277373 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase |
| 08/21/2001 | US6277370 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method |
| 08/21/2001 | US6277369 The selected cells can thereafter be used as vehicles for transferring genes encoding a therapeutic protein to a mammal, including humans. |
| 08/21/2001 | US6277365 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent |
| 08/21/2001 | US6277358 Cosmetic compositions containing crosslinkable polymers |